ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

At AAAS Meeting, David Baltimore Comments on Bush Administration Science Policy.

March 3, 2006

In the Cancer Centers: Rosen Moves To City Of Hope

November 1, 2013

NIH Seeking More Women, Minorities On Committees

November 9, 1979

NIH Director Calls For Lifting Federal Ban on Embryonic Stem Cell Research.

March 23, 2007

Model Projects 54,900 New Lung Cancer Cases In 5 Years with Nationwide LDCT Screening

May 30, 2014

ONS Award Winners, Grantees, Announced At Annual Congress

July 27, 1990